Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Ocana

Showing results (11-20 of 97) with videos related to

Pageof 10
Sort By:
Cancer Metastasis Reviews|October 25, 2012
Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit?Man Yu, Alberto Ocana, Ian F Tannock
Cancers|November 10, 2020
Breast Cancer Heterogeneity and Response to Novel TherapeuticsMariona Baliu-Piqué, Atanasio Pandiella, Alberto Ocana
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2010
Absolute benefits of aromatase inhibitors in adjuvant treatment of breast cancer: should we know more?Bostjan Seruga, Alberto Ocana, Saroj Niraula, et al.
Pharmaceuticals (Basel, Switzerland)|October 26, 2024
Present Scenario and Future Landscape of Payloads for ADCs: Focus on DNA-Interacting AgentsBarbara Valsasina, Paolo Orsini, Chiara Terenghi, et al.
Current Drug Targets|June 13, 2009
Novel tyrosine kinase inhibitors in the treatment of cancerAlberto Ocana, Rosario Serrano, Raul Calero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2010
Do we have to change the way targeted drugs are developed?Alberto Ocana, Eitan Amir, Bostjan Seruga, et al.
Cancer Treatment Reviews|April 14, 2010
Targeting DNA repair in breast cancer: a clinical and translational updateEitan Amir, Bostjan Seruga, Rosario Serrano, et al.
Breast Cancer Research and Treatment|May 8, 2012
Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysisSaroj Niraula, Alberto Ocana, Marguerite Ennis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2015
Failures in Phase III: Causes and ConsequencesBostjan Seruga, Alberto Ocana, Eitan Amir, et al.
Nature Reviews. Clinical Oncology|December 8, 2010
Preclinical development of molecular-targeted agents for cancerAlberto Ocana, Atanasio Pandiella, Lillian L Siu, et al.
Pageof 10

Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
Cancer Metastasis Reviews|October 25, 2012
Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit?Man Yu, Alberto Ocana, Ian F Tannock
Cancers|November 10, 2020
Breast Cancer Heterogeneity and Response to Novel TherapeuticsMariona Baliu-Piqué, Atanasio Pandiella, Alberto Ocana
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2010
Absolute benefits of aromatase inhibitors in adjuvant treatment of breast cancer: should we know more?Bostjan Seruga, Alberto Ocana, Saroj Niraula, et al.
Pharmaceuticals (Basel, Switzerland)|October 26, 2024
Present Scenario and Future Landscape of Payloads for ADCs: Focus on DNA-Interacting AgentsBarbara Valsasina, Paolo Orsini, Chiara Terenghi, et al.
Current Drug Targets|June 13, 2009
Novel tyrosine kinase inhibitors in the treatment of cancerAlberto Ocana, Rosario Serrano, Raul Calero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2010
Do we have to change the way targeted drugs are developed?Alberto Ocana, Eitan Amir, Bostjan Seruga, et al.
Cancer Treatment Reviews|April 14, 2010
Targeting DNA repair in breast cancer: a clinical and translational updateEitan Amir, Bostjan Seruga, Rosario Serrano, et al.
Breast Cancer Research and Treatment|May 8, 2012
Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysisSaroj Niraula, Alberto Ocana, Marguerite Ennis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2015
Failures in Phase III: Causes and ConsequencesBostjan Seruga, Alberto Ocana, Eitan Amir, et al.
Nature Reviews. Clinical Oncology|December 8, 2010
Preclinical development of molecular-targeted agents for cancerAlberto Ocana, Atanasio Pandiella, Lillian L Siu, et al.
Pageof 10